相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signaling
Jan A. Burger et al.
BLOOD (2013)
Chronic lymphocytic leukemia: A tale of one or two signals?
Nicholas Chiorazzi et al.
CELL RESEARCH (2013)
Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
Ranjana H. Advani et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Hairy cell leukemia cell lines expressing annexin A1 and displaying B-cell receptor signals characteristic of primary tumor cells lack the signature BRAF mutation to reveal unrepresentative origins
N. J. Weston-Bell et al.
LEUKEMIA (2013)
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765)
Jan A. Burger et al.
LEUKEMIA & LYMPHOMA (2013)
Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation
Liqiang Xi et al.
BLOOD (2012)
The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo
Sabine Ponader et al.
BLOOD (2012)
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia
Martin F. M. de Rooij et al.
BLOOD (2012)
CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia
Mariela Sivina et al.
BLOOD (2011)
Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia
Farhad Ravandi et al.
BLOOD (2011)
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Sarah E. M. Herman et al.
BLOOD (2011)
The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia
Julia Hoellenriegel et al.
BLOOD (2011)
Hairy-cell leukemia variant: Recent view on diagnosis, biology and treatment
Tadeusz Robak
CANCER TREATMENT REVIEWS (2011)
Hairy cell leukaemia: biological and clinical overview from immunogenetic insights
Francesco Forconi
HEMATOLOGICAL ONCOLOGY (2011)
Molecular insight into the biology and clinical course of hairy cell leukemia utilizing immunoglobulin gene analysis
Francesco Forconi et al.
LEUKEMIA & LYMPHOMA (2011)
The microenvironment in hairy cell leukemia: pathways and potential therapeutic targets
Jan A. Burger et al.
LEUKEMIA & LYMPHOMA (2011)
BRAF Mutations in Hairy-Cell Leukemia
Enrico Tiacci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
Jonathan W. Friedberg et al.
BLOOD (2010)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
Lee A. Honigberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation
Jan A. Burger et al.
BLOOD (2009)
B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406
Maite P. Quiroga et al.
BLOOD (2009)
VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy
Evgeny Arons et al.
BLOOD (2009)
Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis
Monica Else et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia
Francesco Forconi et al.
HAEMATOLOGICA (2008)
Bruton's tyrosine kinase and phospholipase C gamma 2 mediate chemokine-controlled B cell migration and homing
David J. J. de Gorter et al.
IMMUNITY (2007)
Immunophenotyping and differential diagnosis of hairy cell leukemia
Estella Matutes
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2006)
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
JA Burger et al.
BLOOD (2006)
Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia
BT Messmer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Chemokine receptor expression in B-cell lymphoproliferative disorders
SWJ Wong et al.
LEUKEMIA & LYMPHOMA (2004)
Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins
GF Widhopf et al.
BLOOD (2004)
The B cell antigen receptor controls integrin activity through Btk and PLCγ2
M Spaargaren et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vλ2-14 gene use and homologous CDR3s:: implicating recognition of a common antigen epitope
G Tobin et al.
BLOOD (2003)
Differential expression of chemokine receptors in B cell malignancies
J Dürig et al.
LEUKEMIA (2001)
分享论文
